Assignee
APEXIGEN INC
US9 patents
Top patents by PatentIndex Score
US9266956B2Feb 23, 2016
Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodies
APEXIGEN INC22 citations92
US8957193B2Feb 17, 2015
Polynucleotides encoding anti-CD40 antibodies
APEXIGEN INC21 citations92
US9994640B2Jun 12, 2018
Anti-CD40 antibodies
APEXIGEN INC6 citations83
US9676861B2Jun 13, 2017
Anti-CD40 antibodies and methods of use
APEXIGEN INC9 citations83
US9556278B2Jan 31, 2017
Anti-CD40 antibodies
APEXIGEN INC9 citations83
US11001637B2May 11, 2021
Anti-CD40 antibodies
APEXIGEN INC2 citations72
US10259878B2Apr 16, 2019
Anti-RANKL antibodies and methods of use
APEXIGEN INC1 citations62
US11078283B2Aug 3, 2021
Anti-PD-L1 antibodies and methods of use
APEXIGEN INC0 citations51
US9951136B2Apr 24, 2018
Anti-IL-6 receptor antibodies and methods of use
APEXIGEN INC0 citations49